Select Page
  1. Home
  2.  » 
  3. Events
  4.  » CPhI Festival of Pharma
CPhI Festival of Pharma

Schedule to meet with Catalent at CPhI Festival of Pharma

Date: October 5-16, 2020

Location: Virtual Conference

Virtual Booth: Catalent




Julien Meissonnier

VP, Chief Scientific Officer​​, Catalent
Session Title: Roundtable: Innovation in Oncology Development
Date: Wednesday, October 14, 2020
Time: 14:00-15:30 CET
Abstract: ​Within the last decade, there have been huge steps forward in oncology drug development – which has led to a reshaping of the global market. 2019 and 2020 have seen a wave of approvals for therapies which promise to advance care and improve outcomes for patients, including more targeted approached and immunotherapies which has the potential to revolutionize the way we approach oncology treatment.

This roundtable discussion will tackle the following:

  • Drug pipeline and approvals
  • New approaches to drug development for oncology
  • Nanotechnology, Immunotherapy and targeted therapies


Dr. Thomas VanCott
Global Head of Product Development, Cell & Gene Therapy, Catalent
Session Title: Roundtable: Cell & Gene Technology
Date: Friday, October 16, 2020
Time: 14:00-15:30 CET
Abstract: After decades of slow and steady progress and thanks to clinical, manufacturing, and technological advancements, we are beginning to acknowledge the potential of cell and gene therapy. This market growth requires investments in disruptive technologies to enhance safety and activity as well as reduce production costs. Seeking accelerated clinical trials and approvals for advanced therapeutics is on the rise. With many having fast track status designation, it is increasingly critical for innovators to optimize the process, develop an enabling technology that automates and accelerates drug development.

The panel will also discuss:

  • Evaluation of new innovative technologies and process platforms across the entire scale-up and production process
  • Gene Therapy Innovation and Product Development
  • Technology Integrators in Cell and Gene Therapy: Increased Efficiency and Standardization


Cornell Stamoran, Ph.D.
Vice President of Corporate Strategy, Catalent
Session Title: Roundtable – Facing the COVID-19 Crisis: Leadership and the Future of Pharma
Date: Friday, October 16, 2020
Time: 16:00-17:30 CET
Abstract: Members of The Medicine Maker’s 2020 Power List discuss the challenges of leadership during the pandemic – and the lessons the pharma industry must learn as a whole from the crisis. Navigating the impact of COVID-19 has placed increased pressure on pharma leaders to effectively manage remote teams, reassure employees, ensure business continuity, and, most importantly, reduce the impact on patients. Although the crisis is a challenge, it can also bring opportunities. This unprecedented period is a catalyst to strengthen the relationship between all players in the value chain and shape the future of pharma collectively. In this Roundtable discussion, The Medicine Maker gathers experts from its annual Power List to discuss the impact of COVID-19 on the industry and share their insights on the ‘new normal’ for pharma.